The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children

Tissue Antigens

Volumn 74, Issue 4, 2009, Pages 317-321

  Zheng, X Q ^b   Zhu, F ^a   Shi, W W ^a   Lin, A ^a   Yan, W H ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Active infection; Human cytomegalovirus; Human leukocyte antigen G; Polymorphism

Indexed keywords

HLA G ANTIGEN; VIRUS DNA;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; URINE;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; DNA, VIRAL; FEMALE; GASTROINTESTINAL DISEASES; HEPATITIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; MUTAGENESIS, INSERTIONAL; PNEUMONIA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SEQUENCE DELETION;

HUMAN HERPESVIRUS 5;

EID: 70349320395     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01312.x     Document Type: Article

References (33)

1. de Jong MD, Galasso GJ, Gazzard B et al. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res 1998 : 39 : 141 162.
2. Söderberg-Nauclér C, Nelson JY. Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system. Intervirology 1999 : 42 : 314 321.
3. Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol 2006 : 87 : 1763 1779.
4. Lin A, Xu H, Yan W. Modulation of HLA expression in human cytomegalovirus immune evasion. Cell Mol Immunol 2007 : 4 : 91 8.
5. Yan WH, Lin AF. Current opinion on human leukocyte antigen-G in China. Chin Med J (Engl) 2007 : 120 : 1260 1265.
6. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008 : 29 : 125 132.
7. Tripathi P, Agrawal S. The role of human leukocyte antigen E and G in HIV infection. AIDS 2007 : 21 : 1395 1404.
8. Pizzato N, Garmy-Susini B, Le Bouteiller P, Lenfant F. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection. J Reprod Immunol 2004 : 62 : 3 15.
9. Lozano JM, González R, Kindelán JM et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002 : 16 : 347 351.
10. Mégret F, Prehaud C, Lafage M et al. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum Immunol 2007 : 68 : 294 302.
11. Paul P, Cabestre FA, Ibrahim EC et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000 : 61 : 1138 1149.
12. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003 : 64 : 1005 1010.
13. Hviid TV, Hylenius S, Rłørbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003 : 55 : 63 79.
14. Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008 : 72 : 335 341.
15. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002 : 60 : 122 132.
16. Lin A, Yan WH, Xu HH et al. HLA-G expression in human ovarian carcinoma counteracts NK cell function. Ann Oncol 2007 : 18 : 1804 1809.
17. Le Gal FA, Riteau B, Sedlik C et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999 : 11 : 1351 1356.
18. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 2001 : 98 : 12150 12155.
19. Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005 : 35 : 1133 1142.
20. Le Rond S, Azéma C, Krawice-Radanne I et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol 2006 : 176 : 3266 3276.
21. Naji A, Le Rond S, Durrbach A et al. CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 2007 : 110 : 3936 3948.
22. Carosella ED, HoWangYin KY, Favier B, LeMaoult J. HLA-G-dependent suppressor cells: diverse by nature, function, and significance. Hum Immunol 2008 : 69 : 700 707.
23. Contini P, Ghio M, Poggi A et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003 : 33 : 125 134.
24. LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 2005 : 19 : 662 664.
25. Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med 1998 : 188 : 497 503.
26. Barel MT, Ressing M, Pizzato N et al. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J Immunol 2003 : 171 : 6757 6765.
27. Onno M, Pangault C, Le Friec G, Guilloux V, André P, Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000 : 164 : 6426 6434.
28. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004 : 56 : 135 141.
29. Rizzo R, Hviid TV, Stignani M et al. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005 : 57 : 172 181.
30. Pistoia V, Morandi F, Wang X, Ferrone S. Soluble HLA-G: are they clinically relevant? Semin Cancer Biol 2007 : 17 : 469 479.
31. Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001 : 167 : 1877 1881.
32. Rajagopalan S, Bryceson YT, Kuppusamy SP et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006 : 4 : e9.
33. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009 : 22 : 76 98.